- Trials with a EudraCT protocol (266)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
266 result(s) found for: ICD.
Displaying page 1 of 14.
EudraCT Number: 2007-005716-64 | Sponsor Protocol Number: 112233020781 | Start Date*: 2008-08-28 |
Sponsor Name:Universitätsklinik für Psychiatrie des Kindes- und Jugendalters, AKH Wien, Medizinische Universität | ||
Full Title: Elevated elimination rates of quetiapine in adolescent patients with schizophrenia (ICD 10: F 20.-), bipolar affective disorder (ICD 10: F 31.-), disorders in impulse control with current PTSD (ICD... | ||
Medical condition: schizophrenia (ICD 10: F 20.-), bipolar affective disorder (ICD 10: F 31.-), disorders of impulse control with current PTSD (ICD 10: F 43.1) or personality disorder (ICD 10: F 60.-). | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001141-32 | Sponsor Protocol Number: 09.0111p | Start Date*: 2011-04-28 |
Sponsor Name:Isala klinieken department Cardiology | ||
Full Title: Catheter ablation versus Amiodarone to pRevent Future ventricular tachycardia Episodes in patients with a defibrillator and a history of a myocardial infarction | ||
Medical condition: The primary purpose of this randomized study is the assessment of recurrences of sustained VT and ICD therapy for VT or VF after appropriate ICD therapy (ATP or shock) in patients with a history of... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004430-15 | Sponsor Protocol Number: GS-US-356-0101 | Start Date*: 2014-10-07 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Double-Blind, Randomized, Placebo Controlled, Dose Ranging, Parallel Group Study to Evaluate the Effect of GS-6615 on Ventricular Arrhythmia in Subjects with Implantable Cardioverter-Def... | |||||||||||||
Medical condition: Subjects with an ICD or CRT-D implanted for primary or secondary prevention | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) PL (Completed) DK (Completed) CZ (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004799-35 | Sponsor Protocol Number: DRI5349 | Start Date*: 2005-05-25 | |||||||||||
Sponsor Name:Sanofi-aventis recherche and developpement | |||||||||||||
Full Title: Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744C 100 or 300 mg for the prevention of ventricular arrhythmia-triggered ICD interventions | |||||||||||||
Medical condition: Ventricular arrhythmia triggered ICD interventions | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003034-16 | Sponsor Protocol Number: FNOL-IVA-ICD | Start Date*: 2014-05-12 |
Sponsor Name:University Hospital Olomouc | ||
Full Title: Antiarrhythmic and antiremodelation effects of ivabradin in ICD carriers | ||
Medical condition: Heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001229-15 | Sponsor Protocol Number: 6398 | Start Date*: 2019-04-16 |
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
Full Title: Study of pimavanserin efficacy for the treatment of impulse control disorders in Parkinson's disease | ||
Medical condition: Impulse control disorders (ICD) in Parkinson's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004376-11 | Sponsor Protocol Number: AZM-MD-302 | Start Date*: 2012-05-15 | |||||||||||
Sponsor Name:Forest Research Institute, Inc. | |||||||||||||
Full Title: A Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once-Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizat... | |||||||||||||
Medical condition: Ventricular arrhythmia in patients with implantable cardioverter-defibrillator (ICD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) NL (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended) SE (Prematurely Ended) CZ (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011790-32 | Sponsor Protocol Number: 09.0111p | Start Date*: 2010-03-18 |
Sponsor Name:Isala Klinieken Department Cardiology | ||
Full Title: Catheter ablation versus Amiodarone to prevent future shock episodes in patients with a defibrillator and a history of a myocardial infarction. | ||
Medical condition: The main objective of this study is to compare the occurrence of next ICD shock therapy for VT or VF in patients with hospital presentation for an ICD shock therapy for VT or VF, with a history of ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002386-37 | Sponsor Protocol Number: IVN3ICD | Start Date*: 2007-08-24 |
Sponsor Name:Department of Cardiology, Aalborg Hospital | ||
Full Title: Intravenous infusion of n-3 polyunsaturated fatty acids and ventricular tackycardi in patients with implantable cardioverter defibrillator (ICD) | ||
Medical condition: Patients with an implantable cardioverter defibrillator (ICD-unit) for treatment for cardiac ventricular arrhythmias and for prevention of sudden cardiac death | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-008412-47 | Sponsor Protocol Number: DRI10936 | Start Date*: 2009-09-21 | |||||||||||
Sponsor Name:Sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: Double blind placebo controlled dose ranging study of the efficacy and safety of celivarone at 50, 100 or 300 mg OD with Amiodarone as calibrator for the prevention of ICD interventions or death. | |||||||||||||
Medical condition: Ventricular arrhythmia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) HU (Completed) ES (Completed) PT (Completed) BE (Completed) SE (Completed) NL (Completed) IT (Completed) PL (Completed) FI (Completed) CZ (Completed) DK (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002581-14 | Sponsor Protocol Number: DvL-2020-01 | Start Date*: 2020-11-04 |
Sponsor Name:Medical University of Graz, Division of Cardiology | ||
Full Title: Ertugliflozin to Reduce Arrhythmic burden in ICD/CRT patientS (ERASe-Trial) – a phase III Study | ||
Medical condition: Heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-005041-35 | Sponsor Protocol Number: AN 0104 | Start Date*: 2005-10-19 |
Sponsor Name:University Hospital Basel, Dept. of Angiology | ||
Full Title: The effects of physical training, Aspirin, and Clopidogrel on the walking capacity of patients with stage II peripheral arterial disease | ||
Medical condition: Peripheral arterial disease, intermittent claudication | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002188-23 | Sponsor Protocol Number: KLOPOXID2021 | Start Date*: 2021-12-01 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: Association between variations in CYP pheno- and genotypes and plasma concentration of chlordiazepoxide in the treatment of alcohol withdrawal symptoms | |||||||||||||
Medical condition: Alcohol withdrawal symptomps | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002688-10 | Sponsor Protocol Number: 05/S1401/62 | Start Date*: 2005-08-31 |
Sponsor Name:University of Dundee | ||
Full Title: The Effect of omega-3 polyunsaturated Fatty Acid Supplements on Microvolt T-Alternans in Patients with Ventricular Arrythmia | ||
Medical condition: Patients with Implantable Cardioverter Defibrillator(ICD) with ventricular arrythmias | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001287-22 | Sponsor Protocol Number: FLECAINIDE-1 | Start Date*: 2011-04-18 | |||||||||||
Sponsor Name:FONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE | |||||||||||||
Full Title: A Prospective Randomized Crossover trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia | |||||||||||||
Medical condition: Patients with CPVT and ICD | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001464-19 | Sponsor Protocol Number: GE-122-020 | Start Date*: 2016-02-11 | ||||||||||||||||
Sponsor Name:GE Healthcare Ltd. and its affiliates | ||||||||||||||||||
Full Title: AdreView™ Myocardial Imaging for Risk Evaluation – A multicentre trial to guide ICD implantation in NYHA class II & III heart failure patients with 30%≤LVEF≤35% ADMIRE-ICD | ||||||||||||||||||
Medical condition: Heart failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) CZ (Prematurely Ended) DE (Prematurely Ended) DK (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001922-26 | Sponsor Protocol Number: BMI-EU-02-008 | Start Date*: 2006-01-06 |
Sponsor Name:Bioheart, Inc | ||
Full Title: A Phase II, Open-label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Pos... | ||
Medical condition: Patients with congestive heart failure who have had a previous myocardial infarction. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003147-38 | Sponsor Protocol Number: MICRO.HGUGM.2017-14 | Start Date*: 2018-02-16 | |||||||||||
Sponsor Name:Emilio Bouza Santiago | |||||||||||||
Full Title: Open, randomized clinical trial to evaluate the treatment of First Clostridium difficile infection episodes with bacteriotherapy | |||||||||||||
Medical condition: Clostridium difficile infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004034-41 | Sponsor Protocol Number: 21267983 | Start Date*: 2005-11-25 |
Sponsor Name:Genzyme Europe B.V. | ||
Full Title: Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure Phase 2 Study Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Study | ||
Medical condition: Ischemic Heart Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-005688-36 | Sponsor Protocol Number: SCIVF2021 | Start Date*: 2022-09-19 |
Sponsor Name:Amsterdam UMC | ||
Full Title: Quinidine versus verapamil in short-coupled idiopathic ventricular fibrillation: An open label, randomized crossover pilot trial | ||
Medical condition: Short-coupled idiopathic ventricular fibrillation is a rare syndrome and subtype of idiopathic ventricular fibrillation that is characterized by ventricular fibrillation or polymorphic ventricular ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
